This new report from Venture Planning Group contains 1,200 pages, 450 tables and provides forecasts for 40 tumor markers by country and market segment, as well as sales and market shares for reagent and instrument suppliers.... Research Beam Model: Research Beam Product ID: 15149 21100 USD New
World Cancer Diagnostic Testing Market 2014: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities
 

World Cancer Diagnostic Testing Market 2014: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities

World Cancer Diagnostic Testing Market 2014: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportuni

Category : Diagnostic and Biotech
Published On : January  2014

request-discount


TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

Complete report $32,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.


This new report from Venture Planning Group contains 1,200 pages, 450 tables and provides forecasts for 40 tumor markers by country and market segment, as well as sales and market shares for reagent and instrument suppliers. 


The report is available by region, country, section, market segment and individual test:
 

Regions: Global, Europe
 

Countries: France, Germany, Italy, Japan, Spain, UK, USA
 

Sections: Assays, Competitors, Instrumentation, Technologies
 

Market Segments: Hospitals (France, Germany, Italy, Japan, Spain, UK, USA), Personalized Testing
 

Tests: AFP, Beta-2 Microglobulin, CA Tumor Markers, CEA, Cell Surface Markers, Occult Blood, PAP, Pap Smear/HPV, PSA



Enquiry Before Buy